Movement Disorders Program
Dr. Ebrahimi-Fakhari directs the Movement Disorders Program at Boston Children’s Hospital. The team at the Movement Disorders Program provides specialty care for infants, children, and adolescents with genetic and acquired movement disorders. The team includes neurologists with special training in movement disorders, genetic counselors, physical and occupational therapists, and social workers. We work together to develop a treatment plan that meets every child’s unique needs and maximizes quality of life.
The treatment portfolio also includes specialized procedures, such as the treatment of spasticity and dystonia with botulinum toxin injections, and the treatment of dystonia and other hyperkinetic movement disorders with Deep Brain Stimulation (DBS).
Specialists in the Movement Disorders Program lead several research programs and clinical trials that work synergistically with our clinical care. We collaborate closely with clinicians and researchers across North America and internationally.
Tri-Institutional Seminar Series on Pediatric Movement Disorders 2024-2025
This seminar series is organized between the Pediatric Movement Disorders Programs at Boston Children’s Hospital in Boston, the Hospital for Sick Children in Toronto, and Children’s National Medical Center in Washington, D.C..
Date | Speaker | Topic |
---|---|---|
9/5/24 | Course Directors: Carolina Gorodetsky, MD (SickKids) Laura Tochen, MD (Children's National) Darius Ebrahimi-Fakhari, MD, PhD (BCH) | Introduction to the classification and phenomenology of childhood-onset movement disorders |
9/12/24 | Carolina Gorodetsky, MD (SickKids) Laura Tochen, MD (Children's National) Darius Ebrahimi-Fakhari, MD, PhD (BCH) | Introduction to symptomatic management of childhood-onset movement disorders |
9/19/24 | Carolina Gorodetsky, MD The Hospital for Sick Children | Introduction to deep brain stimulation |
10/10/24 | Jonathan Mink, MD, PhD University of Rochester Medical Center | Transient or developmental Movement Disorders and Stereotypies |
10/24/24 | Travis Larsh, MD Cincinnati Children's Hospital | Functional Movement Disorders |
10/31/24 | Tamara Pringsheim, MD Alberta Children's Hospital | Tics & Tourette Syndrome (3 pm EST) |
11/07/24 | Rebecca Lindsay, MD Alberta Children's Hospital | Resident Case Presentation |
12/05/24 | Kathryn Yang, MBChB Boston Children's Hospital | Management of Status Dystonicus |
12/12/24 | Jennifer O'Malley, MD Stanford Medicine Children's Health | Deep Brain Stimulation in the Treatment of Dystonia (3pm EST) |
12/19/24 | Carolina Gorodetsky, MD The Hospital for Sick Children | Deep Brain Stimulation for Status Dystonicus |
1/16/25 | Todd Herrington, MD Massachusetts General Hospital | Research and Clinical Trials in Deep Brain Stimulation |
1/23/25 | Fellow from Boston Children's Hospital | Fellow Case Presentation |
1/30/25 | Terence Sanger, MD Children's Hospital of Orange County | Deep Brain Stimulation in Cerebral Palsy (3 pm EST) |
2/6/25 | Angela Hewitt, MD University of Rochester Medical Center | Childhood-Onset Dystonia |
2/13/25 | Weston Northam, MD Boston Children's Hospital | An Approach to Surgical Management of Spasticity |
2/20/25 | Fellow from The Hospital for Sick Children | Fellow Case Presentation |
2/27/25 | Maria-Roser Pons, MD Agia Sofia Hospital, University of Athens | Infantile and Early Childhood Parkinsonism |
3/6/25 | Lisette Koens, MD University Medical Center Groningen | Myoclonus in Pediatric Movement Disorders |
3/20/25 | Fellow from Boston Children's Hospital | Fellow Case Presentation |
3/27/25 | Vicente Quiroz, MD University of Valparaiso | The Spectrum of Epilepsy-Dyskinesia Syndromes |
4/3/25 | Amy Viehoever, MD Washington University in St. Louis | Overview of GNAO1 and Current Research Developments |
4/24/25 | Shekeeb Mohammad, MD University of Sydney | Autoimmune-Mediated Movement Disorders (4 pm EST) |
5/1/25 | David Lynch, MD Children's Hospital of Philadelphia | Overview of Friedreich's Ataxia |
5/8/25 | Fellow from The Hospital for Sick Children | Fellow Case Presentation |
5/15/25 | Laura Tochen, MD Children's National Hospital | Movement Disorders in Pediatric Leukodystrophies |
5/29/25 | Lifang Dai, MD Beijing Children's Hospital | Pediatric Movement Disorders from a Single Center in China |
6/5/25 | Penny Hogarth, MD Oregon Health & Science University | Overview of Pantothenate Kinase-Associated Neurodegeneration (PKAN) (3 pm EST) |
6/12/25 | Joshua Burns, PhD St. Jude Children's Research Hospital | Digital Outcome Measures in Movement Disorders |
Below is the schedule for the previous season: